Influence of prior influenza vaccination on antibody and B-cell responses.

PloS One
Sanae SasakiHarry B Greenberg

Abstract

Currently two vaccines, trivalent inactivated influenza vaccine (TIV) and live attenuated influenza vaccine (LAIV), are licensed in the USA. Despite previous studies on immune responses induced by these two vaccines, a comparative study of the influence of prior influenza vaccination on serum antibody and B-cell responses to new LAIV or TIV vaccination has not been reported. During the 2005/6 influenza season, we quantified the serum antibody and B-cell responses to LAIV or TIV in adults with differing influenza vaccination histories in the prior year: LAIV, TIV, or neither. Blood samples were collected on days 0, 7-9 and 21-35 after immunization and used for serum HAI assay and B-cell assays. Total and influenza-specific circulating IgG and IgA antibody secreting cells (ASC) in PBMC were detected by direct ELISPOT assay. Memory B cells were also tested by ELISPOT after polyclonal stimulation of PBMC in vitro. Serum antibody, effector, and memory B-cell responses were greater in TIV recipients than LAIV recipients. Prior year TIV recipients had significantly higher baseline HAI titers, but lower HAI response after vaccination with either TIV or LAIV, and lower IgA ASC response after vaccination with TIV than prior year LAIV or ...Continue Reading

References

Oct 19, 1979·JAMA : the Journal of the American Medical Association·K J ShethC Eisenberg
Dec 1, 1977·The Journal of Infectious Diseases·G R NobleW R Dowdle
Jul 1, 1985·The Journal of Infectious Diseases·B R MurphyR M Chanock
Jul 1, 1983·Proceedings of the National Academy of Sciences of the United States of America·M KrystalD C Wiley
Jan 1, 1983·Annual Review of Microbiology·R B Couch, J A Kasel
Nov 7, 1998·The Journal of Infectious Diseases·A S el-MadhunL R Haaheim
Jul 20, 1999·JAMA : the Journal of the American Medical Association·K L NicholJ Wittes
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·D J SmithA S Perelson
May 4, 2001·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·C B BridgesUNKNOWN Advisory Committee on Immunization Practices
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Joshua B PlotkinSimon A Levin
Apr 17, 2004·Journal of Immunological Methods·Shane CrottyRafi Ahmed
Sep 14, 2004·The Pediatric Infectious Disease Journal·Min-Shi LeePaul M Mendelman
Sep 16, 2004·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Feb 8, 2006·Vaccine·Vishal GuptaMichael W Deem
Dec 15, 2006·The New England Journal of Medicine·Suzanne E OhmitArnold S Monto
Jan 30, 2007·The Pediatric Infectious Disease Journal·Alenka M ZemanCornelia L Dekker
Feb 16, 2007·The New England Journal of Medicine·Robert B BelsheUNKNOWN CAIV-T Comparative Efficacy Study Group
Nov 9, 2007·The New England Journal of Medicine·Ian J AmannaMark K Slifka

❮ Previous
Next ❯

Citations

Nov 28, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mark G ThompsonUNKNOWN Pregnancy and Influenza Project Workgroup
Nov 16, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Suzanne E OhmitArnold S Monto
Jan 15, 2014·The Journal of Infectious Diseases·Kuan-Ying Arthur HuangXiao-Ning Xu
Mar 29, 2014·The Journal of Infectious Diseases·Sanae SasakiHarry B Greenberg
Jun 25, 2014·Immunology Letters·Diana Boraschi, Paola Italiani
Oct 29, 2010·The Journal of Infectious Diseases·F Eun-Hyung LeeEdward E Walsh
Jul 12, 2011·Nature Immunology·Helder I NakayaBali Pulendran
Jun 12, 2012·The Pediatric Infectious Disease Journal·Sophia NgBenjamin J Cowling
Feb 16, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Suzanne E OhmitArnold S Monto
Oct 23, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·S SalemiR D Amelio
Jan 12, 2010·Annual Review of Medicine·Suryaprakash Sambhara, Gregory A Poland
Jun 8, 2011·Immunology and Cell Biology·Garry W LynchJohn S Sullivan
Jan 28, 2012·International Immunology·Daniela FrascaBonnie B Blomberg
Dec 22, 2012·Expert Review of Vaccines·Derek T O'HaganGiuseppe Del Giudice
May 27, 2014·Expert Review of Vaccines·Catherine J Luke, Kanta Subbarao
Jul 26, 2012·Expert Review of Vaccines·Markus A RoseUlrich Baumann
Jul 16, 2015·Expert Review of Vaccines·Adam Kenneth Wheatley, Stephen John Kent
Jun 20, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Karina RamirezMarcela F Pasetti
Jan 24, 2016·Molecular Biology and Evolution·Kenneth B HoehnOliver G Pybus
Oct 5, 2010·Ageing Research Reviews·Pierre-Olivier LangRichard Aspinall
Feb 26, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Carlos A DiazGranadosDavid P Greenberg
Jan 24, 2015·Scientific Reports·Jing-Rong WangZhi-Hong Jiang
Aug 7, 2009·American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons·S CandonL Chatenoud
Jan 5, 2011·Immunological Reviews·Philip R DormitzerRino Rappuoli
Aug 21, 2013·Immunological Reviews·Bali PulendranDmitri A Kazmin

❮ Previous
Next ❯

Software Mentioned

SAS
GraphPad
ImmunoSpot
Plus

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.